Alhamadh, M.S.; Alhowaish, T.S.; Mathkour, A.; Altamimi, B.; Alheijani, S.; Alrashid, A.
Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience. Clin. Pract. 2023, 13, 1286-1302.
https://doi.org/10.3390/clinpract13060115
AMA Style
Alhamadh MS, Alhowaish TS, Mathkour A, Altamimi B, Alheijani S, Alrashid A.
Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience. Clinics and Practice. 2023; 13(6):1286-1302.
https://doi.org/10.3390/clinpract13060115
Chicago/Turabian Style
Alhamadh, Moustafa S., Thamer S. Alhowaish, Alaa Mathkour, Bayan Altamimi, Shahd Alheijani, and Abdulrahman Alrashid.
2023. "Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience" Clinics and Practice 13, no. 6: 1286-1302.
https://doi.org/10.3390/clinpract13060115
APA Style
Alhamadh, M. S., Alhowaish, T. S., Mathkour, A., Altamimi, B., Alheijani, S., & Alrashid, A.
(2023). Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience. Clinics and Practice, 13(6), 1286-1302.
https://doi.org/10.3390/clinpract13060115
